1BOLAND E A, GREY M, OSETERLE A, et al. Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia ,improve meta bolicoonerol,and enhance coping in adolescents with type 1 diabetes [J].Diabetes Care,1999, 22(11):1 284-1 779.
2The DCCT Research Group. The effect of intensive treamrent of diabetes on the development and progression of long - term complications in insulin dependent diabetes mellitus[J]. N Engl I Med, 1993,329: 683 - 689.
3Holman RRH for the UKPDS Group.UK prospective diabetes study :3 year update [A]. SCHWARTZ C J,BORM G V R. Eds.new horizons in diabetes mellitus and cardiovascular disease [ M].London:Current Science, 1995.193-198.
4PURRELLO F,RABUAZZA AM.Metabolic factors that affect beta-cell function and survival[J].Diabet Nutr Metab,2000,13(2):84-91.
5Continuous subcutaneous insulin infusion at 25 years:evidence base for the expanding use of insulin pump therapy in type 1 diabetes[J].Diabetes Care,2002,25(3):593-598.Review.
6Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus[J].Pediatr Endocrinol Metab,2002,15(7):1005-1010.
7KAHN SE.The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus[J].Am J Med,2000,108(Suppl 6a):2-8.
8SVITIZ WI.Lipotoxicity and glucotocicity in type 2 diabetes.Effects on development and progression[J].Postgrad Med,2001,109(1):55-59,63-64.
